The p53 R72P polymorphism does not affect the physiological response to ionizing radiation in a mouse model

Area of Science:

• Genetics
• Cancer Biology
• Radiation Oncology

Background:

• The p53 tumor suppressor gene's codon 72 single nucleotide polymorphism (SNP), p53 R72P, influences cellular responses to genotoxic stress.
• Epidemiological data suggest the arginine (R) variant may improve cancer survival and reduce adverse effects from genotoxic treatments compared to the proline (P) variant.

Purpose of the Study:

• To investigate the physiological impact of the p53 R72P polymorphism on responses to ionizing radiation (IR) in controlled mouse models.
• To assess the potential clinical utility of p53 R72P genotyping for personalizing IR cancer therapy.

Main Methods:

• Utilized rigorously controlled mouse populations (controlled for strain background, sex, and age).
• Conducted comprehensive physiological assessments including blood counts, immunohistochemical (IHC) staining, and survival studies.
• Exposed mice to ionizing radiation (IR) to model cancer therapy.

Main Results:

• The p53 R72P polymorphism did not demonstrate differential effects on the physiological response to IR across the studied mouse populations.
• No significant variations in blood counts, tissue responses (IHC), or survival rates were observed between R and P variant carriers post-IR exposure.

Conclusions:

• The p53 R72P polymorphism does not appear to significantly modulate the physiological effects of ionizing radiation in vivo.
• Genotyping for the p53 R72P polymorphism is unlikely to be clinically useful for personalizing cancer treatment strategies involving IR therapy.